Advertisement

Topics

Glaukos Announces Participation in 29th Annual ROTH Conference

07:00 EST 27 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced...

Other Sources for this Article

Glaukos Corporation
Sheree Aronson
VP, Investor Relations
(949) 367-9600 ext 371
saronson@glaukos.com

NEXT ARTICLE

More From BioPortfolio on "Glaukos Announces Participation in 29th Annual ROTH Conference"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...